Toll-like receptor 7 and Toll-like receptor 9 endosomal signaling complex (TLR7/9 endosomal pathway)

The Toll-like receptor 7 and Toll-like receptor 9 endosomal signaling complex is a critical component of the innate immune system responsible for detecting nucleic acids within the endolysosomal compartment (Kawai & Akira, 2011). Toll-like receptor 7 (TLR7) recognizes single-stranded RNA, while Toll-like receptor 9 (TLR9) detects unmethylated CpG DNA, both of which are typically associated with viral or bacterial pathogens. This machinery includes essential regulatory proteins like the chaperone UNC93B1, which facilitates the trafficking of these receptors from the endoplasmic reticulum to the endosomes, and various lysosomal proteases required for receptor activation (Pelka et al., 2018). In autoimmune diseases such as systemic lupus erythematosus (SLE), this system becomes pathologically activated by self-derived nucleic acids, leading to a chronic interferon signature and systemic inflammation (Schrezenmeier & Dörner, 2020). Therapeutic targeting of this axis involves either lysosomotropic agents like hydroxychloroquine, which raise endosomal pH to prevent receptor processing, or highly specific small-molecule dual antagonists like enpatoran that block receptor-ligand interactions (Sakkas et al., 2018). While effective at reducing autoimmune flares, modulating this pathway requires careful management to avoid compromising the host's ability to respond to viral infections.

Other names

TLR7/9 signaling complexEndolysosomal Toll-like receptor pathwayNucleic acid-sensing TLR machineryTLR7/9/UNC93B1 complex

Inhibition of endosomal acidification, direct antagonism of TLR7 and TLR9 receptors, or disruption of receptor trafficking and proteolytic processing within the endolysosomal compartment.